Search Results 981-990 of 16355 for monoclonal antibody

1. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   ... monoclonal antibodies, antibody drug conjugates, radioimmunoconjugates, or T-cell orother cell-based therapies: 4 weeks (2 weeks permissible before the ...

2. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

   Anti-CD20 monoclonal antibody;; An anthracycline-containing chemotherapy regimen. No evidence, suspicion, and/or history of central nervous system (CNS) ...

3. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

   ... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.

4. Immune globulin-hipp (subcutaneous route) - Mayo Clinic

   Description. Immune globulin-hipp injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

5. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

   * Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...

6. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or ...

7. A Study to Evaluate the Safety and Effectiveness of JBH492 in Patients with Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma - Mayo Clinic

   ... monoclonal antibody administration. Any prior history of treatment with maytansine (DM1 or DM4)-based ADC. Known intolerance to a maytansinoid. Patients ...

8. Herd immunity, antibodies and COVID-19 - Mayo Clinic News Network

   Herd immunity happens when a sufficient proportion of a population is immune to an infectious disease, meaning spread from person to person is unlikely. So what ...

9. A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) - Mayo Clinic

   ... antibody (including ipilimumab), or any other antibody or drug ... Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥3) ...

10. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    ... monoclonal antibody against LOXL2, in patients with IPF. Read More on PubMed. Additional contact information. Non-cancer trials contact form. Phone: 800-664 ...